Portable SARS-CoV-2 Sensor Using Freestanding Laser-Induced Graphene

Brasil Notícia Notícia

Portable SARS-CoV-2 Sensor Using Freestanding Laser-Induced Graphene
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 AZoNano
  • ⏱ Reading Time:
  • 52 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 51%

Portable SARS-CoV-2 Sensor Using Freestanding Laser-Induced Graphene ACS_AMI viral sensor SARSCoV2 COVID19

By Bhavna KavetiSep 14 2022Reviewed by Susha Cheriyedath, M.Sc. Early diagnosis of an infectious viral disease can help the patients and health care professionals monitor the outbreaks accurately and provide treatment at the early stage of a disease, avoiding any detrimental consequences. The accuracy of information is essential while monitoring such diseases to prevent any possible pandemics.

Additionally, a protocol was developed for aqueous biological sensing of SARS-CoV-2 spike proteins. Herein, the device was functionalized with coronavirus disease 2019 antibodies, and the wetting dynamic response of graphene sensors was characterized in buffer solution and water. Moreover, the designed device could specifically detect SARS-CoV-2 spike protein.

In most fabrication techniques, the laser-induced graphene remains embedded in the substrate, whose removal requires scraping, which either destroys the material’s structure or delaminates into the polymer and disturbs the morphology of the fabricated surface. In the present study, a FLIG-based resonator was built as a resonative sensor with miniaturized dimensions along with high sensitivity and selectivity toward SARS-CoV-2 spike proteins and their quantification. The FLIG was functionalized with SARS-CoV-2 spike protein antibodies using a pyrene-containing linker that binds strongly to graphene and laser-induced graphene materials.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

AZoNano /  🏆 106. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Intranasal administration of liposomes displaying SARS-CoV-2 antigen induces mucosal immunityIntranasal administration of liposomes displaying SARS-CoV-2 antigen induces mucosal immunityIntranasal administration of liposomes displaying SARS-CoV-2 antigen induces mucosal immunity MDPIOpenAccess UBuffalo SARSCoV2 COVID19 Coronavirus MucosalImmunity
Consulte Mais informação »

Review of COVID-19 in children before and after SARS-CoV-2 Delta and Omicron variant emergenceReview of COVID-19 in children before and after SARS-CoV-2 Delta and Omicron variant emergenceReview of COVID-19 in children before and after SARS-CoV-2 Delta and Omicron variant emergence BioMedCentral SARSCoV2 COVID19 Coronavirus Delta Omicron Variant Children Pandemic
Consulte Mais informação »

Transplacental passage of specific IgG in maternal SARS-CoV-2 infectionTransplacental passage of specific IgG in maternal SARS-CoV-2 infectionTransplacental passage of specific IgG in maternal SARS-CoV-2 infection infection pregnancy COVID19 coronavirus covid SARSCoV2 antibody maternal disease
Consulte Mais informação »

What is the impact of COVID-19 treatments targeting intracellular Neu1?What is the impact of COVID-19 treatments targeting intracellular Neu1?In a new study, researchers assessed the impact of targeting intracellular Neu1 on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Consulte Mais informação »

What is the risk of SARS-CoV-2 infection among gout patients?What is the risk of SARS-CoV-2 infection among gout patients?What is the risk of SARS-CoV-2 infection among gout patients? SARSCoV2 COVID19 Coronavirus Gout GoutPatients
Consulte Mais informação »

Small molecule inhibitor found to be effective against SARS-CoV-2 variantsSmall molecule inhibitor found to be effective against SARS-CoV-2 variantsIn a new study, researchers developed RK-33, a small molecule inhibitor of DDX3, and evaluated its efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs).
Consulte Mais informação »



Render Time: 2025-03-04 21:11:15